Small protective fragments of the Yersinia pestis V antigen (Q41439298)

30 September 2017

title

Small protective fragments of the Yersinia pestis V antigen (English)

1 reference

30 September 2017

0 references

Claire Vernazza

1

1 reference

30 September 2017

Bry Lingard

2

1 reference

30 September 2017

Helen C Flick-Smith

3

1 reference

30 September 2017

Leslie W J Baillie

4

1 reference

30 September 2017

Jim Hill

5

1 reference

30 September 2017

Helen S Atkins

6

1 reference

30 September 2017

language of work or name

English

0 references

publication date

13 March 2009

1 reference

30 September 2017

1 reference

30 September 2017

volume

27

1 reference

30 September 2017

issue

21

1 reference

30 September 2017

page(s)

2775-2780

1 reference

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Function and molecular architecture of the Yersinia injectisome tip complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

A roadmap for the immunomics of category A-C pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

7 January 2021

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

7 January 2021

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

7 January 2021

Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.011

7 January 2021

10.1016/J.VACCINE.2009.03.011

Identifiers

DOI

1 reference

30 September 2017

1 reference